{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:38:38Z","timestamp":1793410718875,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hepatocellular adenoma (HCA) is a benign liver tumour that may be complicated by bleeding or malignant transformation. Present guidelines advise cessation of oral contraceptives and surgical resection if the lesion is still larger than 5 cm at 6 months after diagnosis. The aim of this study was to evaluate whether this 6-month interval is sufficient to expect regression of a large HCA to 5 cm or smaller.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study included all patients with an HCA larger than 5 cm diagnosed between 1999 and 2015 with follow-up of at least 6 months. Medical records were reviewed for patient characteristics, clinical presentation, lesion characteristics, management and complications. Differences in characteristics were assessed between patients kept under surveillance and those who underwent treatment for an HCA larger than 5 cm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Some 194 patients were included, of whom 192 were women. Eighty-six patients were kept under surveillance and 108 underwent HCA treatment. Patients in the surveillance group had a significantly higher BMI (P = 0\u00b7029), smaller baseline HCA diameter (P &amp;lt; 0\u00b7001), more centrally located lesions (P &amp;lt; 0\u00b7001) and were more likely to have multiple lesions (P = 0\u00b7001) than those in the treatment group. There were no significant differences in sex, age at diagnosis, symptoms, complication rates and HCA subtype distribution. Time-to-event analysis in patients managed conservatively and those still undergoing treatment more than 6 months after diagnosis showed that 69 of 118 HCAs (58\u00b75 per cent) regressed to 5 cm or smaller after a median of 104 (95 per cent c.i. 80\u2013128) weeks. Larger HCAs took longer to regress (P &amp;lt; 0\u00b7001). No complications were documented during follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study suggests that a 6-month cut-off point for assessment of regression of HCA larger than 5 cm to no more than 5 cm is too early. As no complications were documented during follow-up, the cut-off point in women with typical, non-\u03b2-catenin-activated HCA could be prolonged to 12 months, irrespective of baseline diameter.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.10594","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T11:43:34Z","timestamp":1504179814000},"page":"1695-1703","source":"Crossref","is-referenced-by-count":36,"title":["Retrospective study on timing of resection of hepatocellular adenoma"],"prefix":"10.1093","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-3862","authenticated-orcid":false,"given":"A J","family":"Klompenhouwer","sequence":"first","affiliation":[{"name":"Department of Surgery, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E E","family":"Br\u00f6ker","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G J","family":"Thomeer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Gaspersz","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"de Man","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J N M","family":"IJzermans","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"2021020617165932900_bjs10594-bib-0001","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","article-title":"Epidemiology of hepatocellular adenoma. The role of oral contraceptive use","volume":"242","author":"Rooks","year":"1979","journal-title":"JAMA"},{"key":"2021020617165932900_bjs10594-bib-0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00000658-197603000-00003","article-title":"Benign liver cell adenoma associated with use of oral contraceptive agents","volume":"183","author":"Baek","year":"1976","journal-title":"Ann Surg"},{"key":"2021020617165932900_bjs10594-bib-0003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-86-2-180","article-title":"Regression of liver cell adenomas associated with oral contraceptives","volume":"86","author":"Edmondson","year":"1977","journal-title":"Ann Intern Med"},{"key":"2021020617165932900_bjs10594-bib-0004","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2036.2011.04772.x","article-title":"Clinical features and natural history of hepatocellular adenomas: the impact of obesity","volume":"34","author":"Bunchorntavakul","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2021020617165932900_bjs10594-bib-0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0168-8278(85)80001-5","article-title":"Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature","volume":"1","author":"Carrasco","year":"1985","journal-title":"J Hepatol"},{"key":"2021020617165932900_bjs10594-bib-0006","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","article-title":"Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature","volume":"24","author":"Labrune","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021020617165932900_bjs10594-bib-0007","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2010.07.022","article-title":"Management of hepatocellular adenoma during pregnancy","volume":"54","author":"Noels","year":"2011","journal-title":"J Hepatol"},{"key":"2021020617165932900_bjs10594-bib-0008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2006.12.007","article-title":"Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"J Hepatol"},{"key":"2021020617165932900_bjs10594-bib-0009","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.gastro.2013.02.032","article-title":"Hepatocellular benign tumors \u2013 from molecular classification to personalized clinical care","volume":"144","author":"Nault","year":"2013","journal-title":"Gastroenterology"},{"key":"2021020617165932900_bjs10594-bib-0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/bjs.9493","article-title":"Risk factors for bleeding in hepatocellular adenoma","volume":"101","author":"Bieze","year":"2014","journal-title":"Br J Surg"},{"key":"2021020617165932900_bjs10594-bib-0011","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype\u2013phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"2021020617165932900_bjs10594-bib-0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"key":"2021020617165932900_bjs10594-bib-0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/bjs.8762","article-title":"Systematic review of haemorrhage and rupture of hepatocellular adenomas","volume":"99","author":"van Aalten","year":"2012","journal-title":"Br J Surg"},{"key":"2021020617165932900_bjs10594-bib-0014","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5009\/gnl.2014.8.3.292","article-title":"Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging","volume":"8","author":"Ryu","year":"2014","journal-title":"Gut Liver"},{"key":"2021020617165932900_bjs10594-bib-0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.11110023","article-title":"Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification","volume":"261","author":"van Aalten","year":"2011","journal-title":"Radiology"},{"key":"2021020617165932900_bjs10594-bib-0016","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL Clinical Practice Guidelines on the management of benign liver tumours","volume":"65","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J Hepatol"},{"key":"2021020617165932900_bjs10594-bib-0017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2021020617165932900_bjs10594-bib-0018","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1445-2197.1994.tb02279.x","article-title":"The safety of elective liver resection in a special unit","volume":"64","author":"Strong","year":"1994","journal-title":"ANZ J Surg"},{"key":"2021020617165932900_bjs10594-bib-0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00464-002-9047-8","article-title":"Laparoscopic liver resection of benign liver tumors","volume":"17","author":"Descottes","year":"2003","journal-title":"Surg Endosc"},{"key":"2021020617165932900_bjs10594-bib-0020","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"de Meijer","year":"2010","journal-title":"Br J Surg"},{"key":"2021020617165932900_bjs10594-bib-0021","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/hpb.12069","article-title":"2012 Liver resections in the 21st century: we are far from zero mortality","volume":"15","author":"Dokmak","year":"2013","journal-title":"HPB (Oxford)"},{"key":"2021020617165932900_bjs10594-bib-0022","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e3182653ece","article-title":"Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes","volume":"36","author":"Bioulac-Sage","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2021020617165932900_bjs10594-bib-0023","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.22417","article-title":"Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification","volume":"48","author":"Laumonier","year":"2008","journal-title":"Hepatology"},{"key":"2021020617165932900_bjs10594-bib-0024","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.24147","article-title":"Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification","volume":"53","author":"Ronot","year":"2011","journal-title":"Hepatology"},{"key":"2021020617165932900_bjs10594-bib-0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2011.02667.x","article-title":"Can a decision-making model be justified in the management of hepatocellular adenoma?","volume":"32","author":"van Aalten","year":"2012","journal-title":"Liver Int"},{"key":"2021020617165932900_bjs10594-bib-0026","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jhep.2016.07.047","article-title":"Evidence of good prognosis of hepatocellular adenoma in post-menopausal women","volume":"65","author":"Klompenhouwer","year":"2016","journal-title":"J Hepatol"},{"key":"2021020617165932900_bjs10594-bib-0027","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11605-015-2942-9","article-title":"Imaging surveillance of hypervascular liver lesions in non-cirrhotic patients","volume":"20","author":"Chun","year":"2016","journal-title":"J Gastrointest Surg"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.10594","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/12\/1695\/36206834\/bjs10594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/12\/1695\/36206834\/bjs10594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T14:18:23Z","timestamp":1621520303000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/104\/12\/1695-1703\/6123007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,8,30]]},"published-print":{"date-parts":[[2017,10,17]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.10594","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,8,30]]}}}